UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | | |
| Date of Report (Date of Earliest Event Reported): | | August 24, 2005 |
Respironics, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| | | |
| Delaware | 000-16723 | 25-1304989 |
_____________________
(State or other jurisdiction | _____________
(Commission | ______________
(I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| | | |
| 1010 Murry Ridge Lane, Murrysville, Pennsylvania | | 15668-8525 |
_________________________________
(Address of principal executive offices) | | ___________
(Zip Code) |
| | | |
| Registrant’s telephone number, including area code: | | 724-387-5200 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On August 24, 2005, the Compensation and Human Resource Committee of Respironics, Inc. approved and executed Amendment No. 2 to the Amended and Restated Employment Agreement, (originally dated April 1, 1999) with Mr. Gerald E. McGinnis, the Company's Chairman. This amendment was effective May 24, 2005 and extended the term of Mr. McGinnis Amended and Restated Employment Agreement through the date of the Annual Shareholders Meeting in November, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Respironics, Inc. |
| | | | | |
| August 24, 2005 | | By: | | /s/ Daniel J. Bevevino
|
| | | | |
|
| | | | | Name: Daniel J. Bevevino |
| | | | | Title: Vice President, and Chief Financial and Principal Accounting Officer |
